Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial
dc.contributor.author | Byakika‑Kibwika, Pauline | |
dc.contributor.author | Nyakato, Patience | |
dc.contributor.author | Lamorde, Mohammed | |
dc.contributor.author | Kiragga, Agnes N. | |
dc.date.accessioned | 2022-01-12T08:32:55Z | |
dc.date.available | 2022-01-12T08:32:55Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Worldwide, malaria ranks as one of the most important causes of morbidity and mortality with 216 million cases and 445,000 deaths in 2016 alone, 90% of cases and deaths occur in Africa and 80% in sub-Saharan Africa Uganda is one of the heavy malaria burden countries where Plasmodium falciparum, which causes the most severe form of disease is the most prevalent [1]. Malaria is transmitted by the female Anopheles mosquito which injects sporozoites into the human host. Sporozoites undergo pre-erythrocytic and erythrocytic stages of multiplication causing erythrocyte rupture with release of merozoites and pro-inflammatory cytokines into circulation, which are responsible for the symptoms. Patients seek medical attention when they begin to experience symptoms of malaria. | en_US |
dc.identifier.citation | Byakika-Kibwika, P., Nyakato, P., Lamorde, M., & Kiragga, A. N. (2018). Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial. Malaria journal, 17(1), 1-6. https://doi.org/10.1186/s12936-018-2552-6 | en_US |
dc.identifier.uri | https://doi.org/10.1186/s12936-018-2552-6 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1204 | |
dc.language.iso | en | en_US |
dc.publisher | Malaria journal | en_US |
dc.subject | Artesunate | en_US |
dc.subject | ACT | en_US |
dc.subject | Malaria | en_US |
dc.subject | Parasite clearance | en_US |
dc.title | Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.pdf
- Size:
- 934.42 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: